Second near-infrared (NIR-II, 1000-1700 nm) optical imaging offers remarkable potential for noninvasive in vivo pathological diagnosis due to its low photon scattering and deep tissue penetration. However, current Nd-, Ho-, and Er-based nanoprobes emit within 1000-1550 nm, limiting efficient emission beyond 1600 nm. Herein, a general Mn doping strategy is proposed to boost NIR-II luminescence beyond 1600 nm in NaLnF₄:Yb/Tm nanocrystals by inducing crystal structure transformation (hexagonal [β] → cubic [α]), tuning phonon energy, and establishing efficient Tm-Mn energy transfer. Due to efficient energy transfer and multiphonon relaxation, α-NaLnF₄:Yb/Tm/Mn exhibited ∼100-fold-enhanced 1632 nm emission versus β-NaLnF₄. Further, inert coating yielded an additional 4-fold enhancement. Utilizing α-NaLuF₄:Yb/Tm/Mn@NaLuF₄ core-shell structures, high-resolution NIR-IIb (>1600 nm) in vivo imaging of intestine, vasculature, and bone fractures was achieved. This work provides a new strategy for designing efficient NIR-IIb nanoprobes for biomedical imaging.
No takes yet. Share an insight, caveat, or question.
Bi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: